Showing results (21-30 of 125) with videos related to
Sort By:
Pageof 13
Nature|September 14, 2018
Author Correction: Enhancer decommissioning by LSD1 during embryonic stem cell differentiationWarren A Whyte, Steve Bilodeau, David A Orlando, et al.Molecular Cancer Therapeutics|August 25, 2017
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse CancersAaron M Goodman, Shumei Kato, Lyudmila Bazhenova, et al.Plos One|May 7, 2020
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumorsJacob Rinaldi, Ethan S Sokol, Ryan J Hartmaier, et al.NPJ Genomic Medicine|November 24, 2023
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancerIlya G Serebriiskii, Valerii A Pavlov, Grigorii V Andrianov, et al.Cancer Immunology Research|April 21, 2019
Phenotypic and Genomic Determinants of Immunotherapy Response Associated with SquamousnessAaron M Goodman, Shumei Kato, Ranajoy Chattopadhyay, et al.Journal of Immunotherapy and Precision Oncology|August 28, 2023
Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant RelapseAndrea Castro, Aaron M Goodman, Zachary Rane, et al.Journal of Hematology & Oncology|March 2, 2017
Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case reportHong Li, Weijie Ma, Ken Y Yoneda, et al.Lung Cancer (Amsterdam, Netherlands)|January 10, 2025
Genomic analysis of comprehensive next generation sequencing data to explore the criteria for MET amplification as an actionable biomarker in NSCLCDavid Chun Cheong Tsui, Jessica K Lee, Candice Francheska B Tambaoan, et al.Genes & Development|June 29, 2010
Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cellsMarion Dejosez, Stuart S Levine, Garrett M Frampton, et al.Cancer Research|May 3, 2022
Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic EffectsNoboru Ishiyama, Matthew O'Connor, Andrei Salomatov, et al.Pageof 13